James S. Hanson Insider Profile

4 Followers
James S. Hanson, General Counsel at G1 Therapeutics, holds 7.50K shares in Fortrea Holdings Inc. (Ticker: FTRE), holds 41.09K shares in G1 Therapeutics (Ticker: GTHX). Most recently, James S. Hanson Bought ― shares of Fortrea Holdings Inc. on Jun 12, 2024 for an estimated value of 50.60K.
tipranks
James S. Hanson

James S. Hanson
G1 Therapeutics (GTHX)
General Counsel

Ranked #16,873 out of 99,335 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

+16.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$176K
100.00%
A breakdown of James S. Hanson's holdings

Insider Roles

Fortrea Holdings Inc.
(FTRE)
GC
Roles that James S. Hanson holds in companies

Most Profitable Insider Trade

Stock:
G1 Therapeutics
(GTHX)
Rating:Informative Sell
Date:Jan 05, 2022 - Jan 05, 2023
Return:+48.70%
The most profitable trade made by James S. Hanson

James S. Hanson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GTHX
G1 Therapeutics
Jan 05, 2023
Uninformative Buy
$293.77K
Fortrea Holdings Inc.
Jun 12, 2024
GC
Informative Buy
50.60K
$176.25K
List of latest transactions for each holding click on a transaction to see James S. Hanson's performance on stock

James S. Hanson insider profile FAQ

What is the percentage of profitable transactions made by James S. Hanson?
The percentage of profitable transactions made by James S. Hanson is 50%.
    What is the average return per transaction made by James S. Hanson?
    The average return per transaction made by James S. Hanson is 16.30%.
      What stocks does James S. Hanson hold?
      James S. Hanson holds: GTHX, FTRE stocks.
        What was James S. Hanson’s latest transaction?
        James S. Hanson latest transaction was an Informative Buy of $50.60K.
          What was James S. Hanson's most profitable transaction?
          James S. Hanson’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
            What is James S. Hanson's role in G1 Therapeutics?
            James S. Hanson's role in G1 Therapeutics is General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.